SAQUINAVIR: 792 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
792
Total FAERS Reports
57 (7.2%)
Deaths Reported
137
Hospitalizations
792
As Primary/Secondary Suspect
22
Life-Threatening
6
Disabilities
Dec 17, 2004
FDA Approved
Discontinued
Status
FDA Application: 020628 ·
First Report: 1996 · Latest Report: 20240401
What Are the Most Common SAQUINAVIR Side Effects?
#1 Most Reported
Lipodystrophy acquired
186 reports (23.5%)
#2 Most Reported
Eyelid ptosis
169 reports (21.3%)
#3 Most Reported
Mitochondrial toxicity
165 reports (20.8%)
All SAQUINAVIR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Lipodystrophy acquired | 186 | 23.5% | 0 | 0 |
| Eyelid ptosis | 169 | 21.3% | 0 | 0 |
| Mitochondrial toxicity | 165 | 20.8% | 0 | 1 |
| Diplopia | 161 | 20.3% | 0 | 0 |
| Foetal exposure during pregnancy | 105 | 13.3% | 9 | 27 |
| Dysphagia | 103 | 13.0% | 5 | 5 |
| Viral mutation identified | 82 | 10.4% | 0 | 2 |
| Drug resistance | 77 | 9.7% | 5 | 10 |
| Progressive external ophthalmoplegia | 74 | 9.3% | 0 | 0 |
| Pathogen resistance | 67 | 8.5% | 0 | 2 |
| Ophthalmoplegia | 66 | 8.3% | 0 | 0 |
| Virologic failure | 66 | 8.3% | 0 | 15 |
| Blood lactic acid increased | 60 | 7.6% | 1 | 10 |
| Treatment failure | 51 | 6.4% | 1 | 0 |
| Anaemia | 41 | 5.2% | 2 | 25 |
| Drug ineffective | 37 | 4.7% | 13 | 13 |
| Fatigue | 34 | 4.3% | 4 | 6 |
| Pyrexia | 32 | 4.0% | 5 | 26 |
| Hypertension | 24 | 3.0% | 0 | 11 |
| Multiple-drug resistance | 24 | 3.0% | 0 | 8 |
Who Reports SAQUINAVIR Side Effects? Age & Gender Data
Gender: 27.5% female, 72.5% male. Average age: 44.3 years. Most reports from: CA. View detailed demographics →
Is SAQUINAVIR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 12 | 1 | 8 |
| 2001 | 26 | 2 | 8 |
| 2002 | 6 | 3 | 3 |
| 2003 | 8 | 0 | 0 |
| 2005 | 20 | 0 | 0 |
| 2006 | 10 | 0 | 3 |
| 2007 | 3 | 0 | 0 |
| 2008 | 7 | 0 | 0 |
| 2009 | 17 | 1 | 0 |
| 2010 | 5 | 0 | 0 |
| 2011 | 17 | 6 | 1 |
| 2012 | 6 | 2 | 2 |
| 2013 | 5 | 3 | 0 |
| 2014 | 18 | 4 | 13 |
| 2015 | 15 | 0 | 7 |
| 2016 | 1 | 1 | 0 |
| 2017 | 2 | 0 | 0 |
| 2018 | 17 | 4 | 10 |
| 2019 | 3 | 0 | 3 |
| 2021 | 4 | 0 | 3 |
| 2022 | 6 | 0 | 0 |
| 2024 | 5 | 0 | 5 |
What Is SAQUINAVIR Used For?
SAQUINAVIR vs Alternatives: Which Is Safer?
SAQUINAVIR vs SARECYCLINE
SAQUINAVIR vs SARGRAMOSTIM
SAQUINAVIR vs SARILUMAB
SAQUINAVIR vs SATRALIZUMAB
SAQUINAVIR vs SATRALIZUMAB-MWGE
SAQUINAVIR vs SAXAGLIPTIN
SAQUINAVIR vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SAQUINAVIR vs SCOPOLAMINE
SAQUINAVIR vs SCOPOLAMINE HYDROBROMIDE
SAQUINAVIR vs SEBELIPASE ALFA
Official FDA Label for SAQUINAVIR
Official prescribing information from the FDA-approved drug label.